Time Since Last Drug Exposure in Pregnancy Determines Adalimumab and Infliximab Levels in Neonates (Era Study)

Trial Profile

Time Since Last Drug Exposure in Pregnancy Determines Adalimumab and Infliximab Levels in Neonates (Era Study)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Oct 2015

At a glance

  • Drugs Adalimumab (Primary) ; Infliximab (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Pharmacokinetics
  • Acronyms ERA
  • Most Recent Events

    • 15 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top